Albert Bourla (born October 21, 1961, in Thessaloniki, Greece) is a Greek-American veterinarian and pharmaceutical executive who serves as the CEO and Chairman of Pfizer. He comes from a Sephardic Jewish family with roots in Kastoria, Greece; his parents were among the few Jewish survivors of the Holocaust in their community. Bourla earned his Doctor of Veterinary Medicine (DVM) from the Aristotle University of Thessaloniki in 1985 and later obtained an MBA from the same institution. He joined Pfizer in 1993 as technical director for the animal health division in Greece and advanced through various leadership positions, becoming CEO on January 1, 2019, and chairman in April 2019. Under his leadership, Pfizer developed and distributed the COVID-19 vaccine in partnership with BioNTech, a pivotal achievement during the global pandemic. Bourla is married to Myriam Alizé, has two daughters, holds dual Greek and American citizenship, and resides in the United States. He has been recognized with awards such as Forbes CEO of the Year in 2021 and is known for his advocacy in global health and innovation, though his tenure has also drawn scrutiny over vaccine pricing, intellectual property, and public health policies.